Home » Topics » BioWorld Science

BioWorld Science
RSS

U.K. launch for Posicor

Jan. 27, 1998

Wyeth-Ayerst licenses PEPCK-modulating compounds

Jan. 27, 1998

ACAT-inhibitory anilides from Kowa are particularly useful for atherosclerosis

Jan. 27, 1998

Takeda discloses compounds that upregulate LDL receptors

Jan. 27, 1998

Antifungal antibiotics isolated by Takara Shuzo

Jan. 27, 1998

ADIR prepares MMP inhibitors for arthritis, cancer, atherosclerosis

Jan. 27, 1998

Protein farnesyltransferase inhibitors patented by Pfizer for cancer

Jan. 27, 1998

Resistance modulators for use in cancer and malaria developed at Lilly

Jan. 27, 1998

New approach to cancer therapy reported

Jan. 27, 1998

Lilly researchers prepare novel 5-HT reuptake inhibitors

Jan. 27, 1998

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...